Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran.
about
Safety of intravenous iron formulations: facts and folkloreConsiderations and challenges in defining optimal iron utilization in hemodialysisOn the relative safety of parenteral iron formulationsSafety of intravenous iron in hemodialysis patients.Ferumoxytol for the treatment of iron deficiency.Safe administration of iron sucrose in a patient with a previous hypersensitivity reaction to ferric gluconate.Intravenous iron replacement with sodium ferric gluconate complex in sucrose for iron deficiency anemia in adults.The management of anemia in pediatric peritoneal dialysis patients. Guidelines by an ad hoc European committee.Iron, anaemia, and inflammatory bowel diseases.Effect of Intravenous Iron Supplementation on Acute Mountain Sickness: A Preliminary Randomized Controlled Study.Comparison of oxidative stress and inflammation induced by different intravenous iron sucrose similar preparations in a rat modelStrategies to optimize the use of erythropoietin and iron therapy in oncology patients.Understanding renal posttransplantation anemia in the pediatric population.Iron deficiency anaemia in pregnancy and postpartum: pathophysiology and effect of oral versus intravenous iron therapy.Benefits and risks of iron therapy for chronic anaemias.Intravenous iron therapy: well-tolerated, yet not harmless.Haemodialysis-associated anaphylactic and anaphylactoid reactions.Drug insight: Safety of intravenous iron supplementation with sodium ferric gluconate complex.Ferumoxytol for treating iron deficiency anemia in CKDShort-term benefits and risks of intravenous iron: a systematic review and meta-analysis.Safety issues with intravenous iron products in the management of anemia in chronic kidney diseaseA Comparative Look at the Safety Profiles of Intravenous Iron Products Used in the Hemodialysis Population.How we diagnose and treat iron deficiency anemia.Single-dose intravenous iron for iron deficiency: a new paradigm.The available intravenous iron formulations: History, efficacy, and toxicology.Treatment of renal anemia: Erythropoiesis stimulating agents and beyond.The rise and rise of randomized clinical evidence in Sub-Saharan Africa.Single-dose pharmacokinetics of sodium ferric gluconate complex in iron-deficient subjects.Sodium ferric gluconate causes oxidative stress but not acute renal injury in patients with chronic kidney disease: a pilot study.Update on adverse drug events associated with parenteral iron.Nebivolol reduces experimentally induced warm renal ischemia reperfusion injury in rats.The comparative safety of various intravenous iron preparations in chronic kidney disease patients.Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.Acute hypersensitivity reaction to ferric gluconate in a premedicated patient.Comparative Evaluation of U.S. Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection: In Vitro Cellular Uptake.Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease.
P2860
Q26853397-8B4308B0-BC56-45BC-95DA-486F9B28D027Q28088564-A25C280E-B27A-4945-BA69-7366BE4E7BC0Q28262418-ADC52DF3-E926-4DCC-9007-05FE9B7AC2BBQ30234981-C0CA232F-EB40-47EA-AA21-A2857C544964Q30454001-B22AD3AB-986F-4EA1-B441-059CFEC231D2Q33279821-4A7E4E01-FE2B-4723-8CA9-78289F16801EQ33738876-065AE180-950A-4F37-B8C7-44A7411934CEQ35128983-5654FE63-C38B-4F17-8029-901A0FA325CFQ35596692-A5A1437C-7D81-4A1C-87CD-568EA7173383Q35891670-D91C75BD-B69E-4896-AEAF-700B0B0CDF27Q35931905-99B8EEFB-5C49-420A-BCCF-2DCA35C71776Q35976513-F4A69F79-CD1B-4557-B834-D151618576C6Q35996211-ADB9D5F6-BE23-4239-AF34-655BBA2B15E3Q36076079-4F05717F-7DE4-483F-886F-5185051B8E01Q36310898-5D4D95FB-63C1-44EE-91BD-41F010132A9FQ36310902-87169C46-581E-4EC8-A78B-361F1A248FD0Q36366935-E8ACF0E0-BB1C-4A47-87BA-93ADADB98A7FQ36577123-301D3E0F-41E9-4B2B-A9B1-7D7B1A71053AQ36796801-0C13ED6C-7625-4C5B-9D34-6E8780C06826Q36946004-59A82E21-1407-4298-8B93-994B411151F7Q37161960-AFAD1734-ABC8-4C36-9DF1-6D34625EC55AQ37838114-F36E0D3A-F17A-4755-B6DB-C63267001D32Q38593099-8745C4A9-A656-4176-9441-F6D24E41CF34Q39027699-38E51EB1-F484-4FBA-80B2-DCEE55385B30Q39216462-1F226F32-B411-49F2-A60A-2BC014FAB3C4Q41387413-BA8991AD-7F6C-4939-A43D-CDC4F190A619Q42350634-F94220DA-FCAD-406A-AB61-4075769A9140Q44910309-83F5049F-B5A4-4AC7-AB1F-B922726420B0Q45136882-C43692AE-682D-4739-8031-54A59D938423Q46212164-4506836E-CC54-44E6-9F0B-6FB6FF9EC451Q46313772-D1DEB43A-B323-428E-907A-2EBBDE2F7CFAQ46459696-2897CCE9-E84B-48B2-8D0E-A3EFF4D1B445Q46796463-DB2092CA-8C41-4E31-822A-C8EA282DBB51Q46803781-6F64950A-1E8F-433E-BA40-6337C054E003Q47103693-0073D043-CD44-49C2-A0BD-9D6B566529C9Q47111895-636C1812-83A9-4185-9887-1D17BB0BA368
P2860
Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Sodium ferric gluconate comple ...... d to placebo and iron dextran.
@ast
Sodium ferric gluconate comple ...... d to placebo and iron dextran.
@en
Sodium ferric gluconate comple ...... d to placebo and iron dextran.
@nl
type
label
Sodium ferric gluconate comple ...... d to placebo and iron dextran.
@ast
Sodium ferric gluconate comple ...... d to placebo and iron dextran.
@en
Sodium ferric gluconate comple ...... d to placebo and iron dextran.
@nl
prefLabel
Sodium ferric gluconate comple ...... d to placebo and iron dextran.
@ast
Sodium ferric gluconate comple ...... d to placebo and iron dextran.
@en
Sodium ferric gluconate comple ...... d to placebo and iron dextran.
@nl
P2093
P1433
P1476
Sodium ferric gluconate comple ...... d to placebo and iron dextran.
@en
P2093
Allen R Nissenson
Beckie Michael
Daniel W Coyne
David G Warnock
Ferrlecit Publication Committee
J Richard Trout
Joseph W Eschbach
Jur Strobos
Rajiv Agarwal
Robert Lynn
P304
P356
10.1046/J.1523-1755.2002.00314.X
P407
P577
2002-05-01T00:00:00Z
P5875
P6179
1017968576